Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

The following is a summary of “Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies,” published in the September 2024 ...

The study did not provide details on the proportion of patients with therapy-related or secondary acute myeloid leukaemia, and on those with a poor or intermediate-risk karyotype. Complete remission ...

The researchers suggest certain refinements to the 2022 European LeukemiaNet classification model for patients aged 60 years ...

About two-thirds of blast phase CML cases transform into a disease resembling Acute Myeloid Leukaemia, with the remainder transforming into one resembling Acute Lymphoblastic Leukaemia.

September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic ...

Working to drive significant value creation with INB-100 for AML; ongoing trial is actively enrolling additional ...

Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors AML is a genetically heterogeneous disease, ...

It can determine that you have CLL and not another form of leukemia. The test can also help doctors stage your cancer and better understand your outlook. Once a doctor diagnoses and stages CLL ...

Sangeetha Venugopal, MD, MS, discusses the dynamic landscape of molecular targets in acute myeloid leukemia. The molecular landscape of acute myeloid leukemia (AML) is constantly changing. Genetic ...

Mouth sores are common with some types of leukemia. In fact, some researchers say newly appearing mouth ulcers and swollen gums may be an early sign of AML. These changes may happen because of low ...

In the bone marrow, the acquisition of somatic mutations in leukemia-associated genes ... Despite the established link between RUNX1-FPD and hematologic malignancies, there remains a significant gap ...